Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP14 | P54578 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.31 |
| ▸ | PDE9A | O76083 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22158373 | 0.94 | PDE9A (0.34) | USP14GRM4PDE9A | |
| SCHEMBL22156442 | 0.89 | ALDH1A1 (0.33) | ALDH1A1CYP2A6PDE9A | |
| SCHEMBL22156453 | 0.86 | GRM4 (0.34) | USP14ALDH1A1CYP2A6GRM4PDE9A | |
| SCHEMBL22158371 | 0.86 | PDE9A (0.34) | ALDH1A1PDE9A | |
| SCHEMBL23299808 | 0.84 | ALDH1A1 (0.35) | USP14ALDH1A1CYP2A6 | |
| SCHEMBL21414227 | 0.83 | ALDH1A1 (0.39) | USP14ALDH1A1CYP2A6PDE9ACYP19A1 | |
| SCHEMBL22156444 | 0.83 | KIF11 (0.36) | — | |
| SCHEMBL22156450 | 0.82 | PDE9A (0.36) | USP14GRM4PDE9A | |
| SCHEMBL19912352 | 0.82 | ALDH1A1 (0.38) | USP14ALDH1A1CYP2A6CYP19A1 | |
| SCHEMBL26776845 | 0.82 | PDE9A (0.40) | USP14ALDH1A1CYP2A6GRM4PDE9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | USP14 4726/4885ALDH1A1 1882/4885CYP2A6 2606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.